Healthcare regulation company Frier Levitt has analyzed FDA enforcement actions towards “investigation only” peptide sellers. Their conclusion: the FDA considers a product’s classification based upon its supposed use, not its disclaimers. When Internet websites incorporate dosage guides, reconstitution Directions, or hyperlink to forums discu